Clinical implications of physiological changes in the aging heart

K G Pugh1, J Y Wei

  • 1Beth Israel Deaconess Medical Center Department of Medicine, Division of Gerontology, Boston, Massachusetts 02215, USA.

Drugs & Aging
|May 9, 2001
PubMed

Insights

Cardiovascular disease is a major concern for the elderly. Regular exercise and proper medical care can significantly improve cardiovascular health in older adults, distinguishing normal aging from disease.

Area of Science:

  • Geriatric Medicine
  • Cardiovascular Aging
  • Exercise Physiology

Background:

  • Elderly individuals disproportionately suffer from cardiovascular disease, impacting future medical practice.
  • Physicians often lack geriatric training, leading to misdiagnosis of age-related changes versus disease.
  • Sedentary lifestyles contribute significantly to perceived age-related cardiovascular decline.

Purpose of the Study:

  • To elucidate the physiological changes in the aging cardiovascular system.
  • To differentiate normal aging from pathological cardiovascular conditions in the elderly.
  • To explore the impact of lifestyle and potential interventions on cardiovascular aging.

Main Methods:

  • Review of physiological changes associated with aging, including myocyte loss, hypertrophy, and calcification.
  • Analysis of factors affecting cardiac output, myocardial relaxation, and heart rate regulation in older adults.
  • Examination of the role of oxidative stress, inflammation, and gene expression in cardiovascular aging.

Main Results:

  • Aging leads to myocyte loss, hypertrophy, conduction system calcification, and decreased arterial compliance.
  • Reduced early diastolic filling and slowed myocardial relaxation are common, despite maintained basal cardiac output.
  • Exercise, particularly endurance training, shows significant benefits for cardiovascular aging parameters, including oxygen consumption and arterial stiffness.

Conclusions:

  • While cardiovascular aging involves structural and functional changes, many are exacerbated by lifestyle factors.
  • Exercise interventions can favorably impact key cardiovascular aging markers.
  • Distinguishing normal aging from disease and implementing preventive strategies are crucial for reducing cardiovascular morbidity and mortality in the elderly.

Related Concept Videos

The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...